All In Biotech

Drug Trial Radar · NCT06603623

Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine

Phase 2 Double-Blind, Randomized, Placebo Controlled, Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine

Last checked: Nov 20, 2026Latest source record: Feb 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 647 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

647

Actual

Start

Oct 10, 2024

Primary completion

Mar 24, 2025

Study completion Mar 28, 2025

Sponsor

Lead sponsor
Biohaven Therapeutics Ltd.Industry
Sponsor type
Industry
First posted
Sep 19, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.

Conditions

  • Migraine

Interventions

  • BHV-2100Drug

    BHV-2100 75mg

  • BHV-2100Drug

    BHV-2100 150 mg

  • PlaceboDrug

    matching placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Freedom From Pain at 2 Hours Post-doseTime frame: 2 hours post-dose
  2. Percentage of Participants With Freedom From Most Bothersome Symptom (MBS) at 2 Hours Post-doseTime frame: 2 hours post-dose

Locations

60 sites in 1 country. Site status is shown where the registry gives one.

  • MD First Research

    Gilbert, Arizona

  • WR-PRI, LLC (Encino)

    Encino, California

  • Cenexel CNS Los Alamitos

    Los Alamitos, California

  • Clinical Research Institute

    Los Angeles, California

  • WR-PRI, LLC (Newport Beach)

    Newport Beach, California

  • Cenexel CIT IE

    Riverside, California

  • Hasbani Neurology

    New Haven, Connecticut

  • Ki Health Partners DBA/ New England Institute for Clinical Research

    Stamford, Connecticut

  • Green Leaf Clinical Trials

    Jacksonville, Florida

  • WR-MSRA (Multi-Specialty Research Associates)

    Lake City, Florida

  • AppleMed Research Group

    Miami, Florida

  • Ideal Research

    Pembroke Pines, Florida

  • ForCare Clinical Research

    Tampa, Florida

  • Premier Research Instiute

    West Palm Beach, Florida

  • NeuroTrials Research, Inc.

    Atlanta, Georgia

  • Velocity Clinical Research, Savannah

    Savannah, Georgia

  • Chicago Headache Center & Research Center

    Chicago, Illinois

  • Healthcare Research Network II, LLC

    Flossmoor, Illinois

  • Velocity Clinical Research, Sioux City

    Sioux City, Iowa

  • Integrated Clinical Trials Services

    West Des Moines, Iowa

  • Collective Medical Research

    Overland Park, Kansas

  • L-MARC Research Center

    Louisville, Kentucky

  • Crescent City Headache & Neurology

    Chalmette, Louisiana

  • DelRicht Research

    New Orleans, Louisiana

  • Velocity Clinical Research, Rockville

    Rockville, Maryland

  • Boston Clinical Trials

    Boston, Massachusetts

  • Neurology Center of New England PC

    Foxborough, Massachusetts

  • MedVadis Research Corp

    Waltham, Massachusetts

  • Mass Institute of Clinical Research

    Westborough, Massachusetts

  • Michigan Head Pain and Neurological Institute

    Ann Arbor, Michigan

  • Quest Research Institute

    Farmington Hills, Michigan

  • Clinical Research Institute

    Minneapolis, Minnesota

  • StudyMedrix Research

    City of Saint Peters, Missouri

  • Alliance for Multispecialty Research - Kansas City

    Kansas City, Missouri

  • Clinvest Research

    Springfield, Missouri

  • WR-CRNC (Wake Research)

    Las Vegas, Nevada

  • ActivMed Practices & Research-Portsmouth/Pease

    Portsmouth, New Hampshire

  • Albuquerque Clinical Trials

    Albuquerque, New Mexico

  • Fieve Clinical Research, Inc.

    New York, New York

  • Rochester Clinical Research

    Rochester, New York

Showing 40 of 60 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.